We are live on ! Find out more
Northern Trust

Northern Trust Portfolio holdings

AUM $757B
1-Year Est. Return 28.64%
 

Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.

This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+28.64%
3 Year Est. Return
+94.48%
5 Year Est. Return
+125.76%
10 Year Est. Return
+473.22%
AUM
$520B
AUM Growth
+$16B
Cap. Flow
-$18.7B
Cap. Flow %
-3.6%
Top 10 Hldgs %
23.14%
Holding
4,684
New
107
Increased
2,129
Reduced
1,968
Closed
152

Top Buys

Rank Stock Value
1
GUNR icon
FlexShares Global Upstream Natural Resources Index Fund
GUNR
+$288M
2
ESGU icon
iShares ESG Aware MSCI USA ETF
ESGU
+$256M
3
USHY icon
iShares Broad USD High Yield Corporate Bond ETF
USHY
+$180M
4
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$163M
5
PANW icon
Palo Alto Networks
PANW
+$149M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.5B
2
MSFT icon
Microsoft
MSFT
+$1.41B
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$448M
4
NVDA icon
NVIDIA
NVDA
+$434M
5
AMZN icon
Amazon
AMZN
+$432M

Sector Composition

Rank Sector Weight
1 Technology 25.26%
2 Healthcare 12.37%
3 Financials 10.77%
4 Consumer Discretionary 9.82%
5 Industrials 8.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADIL
4501
Adial Pharmaceuticals
ADIL
$6.89M
$6.18K ﹤0.01%
48
– –
ARDS
4502
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$6.18K ﹤0.01%
28,104
– –
ENSV
4503
DELISTED
Enservco Corp.
ENSV
$6.09K ﹤0.01%
18,920
– –
SIDU icon
4504
Sidus Space
SIDU
$164M
$5.89K ﹤0.01%
326
– –
TBLT
4505
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
$5.88K ﹤0.01%
303
– –
ISUN
4506
DELISTED
iSun, Inc. Common Stock
ISUN
$5.88K ﹤0.01%
14,705
– –
SBIG
4507
DELISTED
SpringBig Holdings, Inc. Common Stock
SBIG
$5.76K ﹤0.01%
12,945
– –
FOXO
4508
DELISTED
FOXO TECHNOLOGIES INC A
FOXO
$5.74K ﹤0.01%
93
– –
NTRP icon
4509
NextTrip
NTRP
$24.5M
$5.67K ﹤0.01%
812
– –
AIFF
4510
Firefly Neuroscience
AIFF
$16.7M
$5.62K ﹤0.01%
614
– –
ACB
4511
Aurora Cannabis
ACB
$169M
$5.35K ﹤0.01%
+1,000
New +$5.89K
AKA icon
4512
a.k.a. Brands
AKA
$119M
$5.04K ﹤0.01%
977
-5,463
-85% -$26.7K
NCMI icon
4513
National CineMedia
NCMI
$378M
$5K ﹤0.01%
1,484
-13,518
-90% -$40.7K
SFR
4514
DELISTED
Appreciate Holdings, Inc. Class A Common Stock
SFR
$4.5K ﹤0.01%
12,500
– –
BACK
4515
DELISTED
IMAC Holdings, Inc. Common Stock
BACK
$4.19K ﹤0.01%
1,270
– –
SLNH icon
4516
Soluna Holdings
SLNH
$180M
$3.96K ﹤0.01%
777
– –
IMBI
4517
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$3.91K ﹤0.01%
29,596
– –
AVTX icon
4518
Avalo Therapeutics
AVTX
$1.01B
$3.85K ﹤0.01%
45
– –
NAVB
4519
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$3.63K ﹤0.01%
39,414
– –
NEXI
4520
DELISTED
NexImmune, Inc. Common Stock
NEXI
$3.57K ﹤0.01%
507
– –
DMS
4521
DELISTED
Digital Media Solutions, Inc.
DMS
$3.51K ﹤0.01%
710
– –
LGL.WS
4522
DELISTED
LGL Group Inc Warrants
LGL.WS
$3.32K ﹤0.01%
22,155
– –
CRKN
4523
DELISTED
Crown Electrokinetics Corp. Common Stock
CRKN
– –
0
– –
BJDX icon
4524
Bluejay Diagnostics
BJDX
$909K
– –
0
– –
BNTC icon
4525
Benitec Biopharma
BNTC
$414M
$2.82K ﹤0.01%
695
– –
179 180
181
182 183

Similar funds

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust's Q2 2023 Portfolio in Review

As of Q2 2023, Northern Trust held 4,684 positions worth $520B, up 3.2% from $504B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Northern Trust withdrew a net $18.7B in Q2 2023, closing 152 positions and reducing 1,968 holdings. Its most notable exit was ABB Ltd, an estimated $112M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Northern Trust opened a new position in Crane Co worth $39.5M.

  • Northern Trust's largest Q2 2023 buy was Crane Co: 442,777 shares worth $39.5M.
  • Northern Trust added most to FlexShares Global Upstream Natural Resources Index Fund in Q2 2023, an estimated $288M increase.
  • Northern Trust's biggest Q2 2023 reduction was Apple, cutting an estimated $1.5B.
  • Northern Trust fully exited ABB Ltd in Q2 2023, selling an estimated $112M.
  • Northern Trust's ten largest holdings make up 23% of its $520B portfolio in Q2 2023.
  • Northern Trust opened 107 new positions and closed 152 in Q2 2023.
  • Northern Trust's portfolio value rose 3.2% quarter-over-quarter to $520B.

Based on Northern Trust's 13F filing for Q2 2023, filed 11 Aug 2023.